JP2011506447A5 - - Google Patents

Download PDF

Info

Publication number
JP2011506447A5
JP2011506447A5 JP2010537971A JP2010537971A JP2011506447A5 JP 2011506447 A5 JP2011506447 A5 JP 2011506447A5 JP 2010537971 A JP2010537971 A JP 2010537971A JP 2010537971 A JP2010537971 A JP 2010537971A JP 2011506447 A5 JP2011506447 A5 JP 2011506447A5
Authority
JP
Japan
Prior art keywords
connexin
agent
polynucleotide
pharmaceutical composition
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010537971A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011506447A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/013656 external-priority patent/WO2009075882A2/en
Publication of JP2011506447A publication Critical patent/JP2011506447A/ja
Publication of JP2011506447A5 publication Critical patent/JP2011506447A5/ja
Withdrawn legal-status Critical Current

Links

JP2010537971A 2007-12-11 2008-12-11 損傷した創傷治癒組成物および治療 Withdrawn JP2011506447A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US726207P 2007-12-11 2007-12-11
PCT/US2008/013656 WO2009075882A2 (en) 2007-12-11 2008-12-11 Impaired wound healing compositions and treatments

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014097425A Division JP2014144976A (ja) 2007-12-11 2014-05-09 損傷した創傷治癒組成物および治療

Publications (2)

Publication Number Publication Date
JP2011506447A JP2011506447A (ja) 2011-03-03
JP2011506447A5 true JP2011506447A5 (enExample) 2013-01-31

Family

ID=40626592

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010537971A Withdrawn JP2011506447A (ja) 2007-12-11 2008-12-11 損傷した創傷治癒組成物および治療
JP2014097425A Withdrawn JP2014144976A (ja) 2007-12-11 2014-05-09 損傷した創傷治癒組成物および治療
JP2016082856A Pending JP2016135799A (ja) 2007-12-11 2016-04-18 損傷した創傷治癒組成物および治療

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014097425A Withdrawn JP2014144976A (ja) 2007-12-11 2014-05-09 損傷した創傷治癒組成物および治療
JP2016082856A Pending JP2016135799A (ja) 2007-12-11 2016-04-18 損傷した創傷治癒組成物および治療

Country Status (8)

Country Link
US (1) US20100279921A1 (enExample)
EP (1) EP2245158A2 (enExample)
JP (3) JP2011506447A (enExample)
CN (2) CN102920996A (enExample)
AU (2) AU2008335718A1 (enExample)
CA (1) CA2709153A1 (enExample)
WO (1) WO2009075882A2 (enExample)
ZA (1) ZA201004998B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101573131B (zh) 2005-02-03 2017-12-01 科达治疗有限公司 抗‑连接蛋白化合物及其治疗应用
PL2101791T3 (pl) 2006-12-11 2015-04-30 Coda Therapeutics Inc Preparaty i metody leczenia ran z nieprawidłowym przebiegiem gojenia
AU2008343754A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin polynucleotides for the treatment of surgical adhesions
EP2237796A2 (en) * 2007-12-21 2010-10-13 Coda Therapeutics, Inc. Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions
EP2237795A2 (en) * 2007-12-21 2010-10-13 Coda Therapeutics, Inc. Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions
US20110243964A1 (en) * 2007-12-21 2011-10-06 Bradford James Duft Treatment of orthopedic conditions
CA2710380A1 (en) 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin 43 poly nucleotide for the treatment of fibrotic conditions
EP2234656A2 (en) 2007-12-21 2010-10-06 Coda Therapeutics, Inc. Improved medical devices
JP2011507860A (ja) * 2007-12-21 2011-03-10 コーダ セラピューティクス, インコーポレイテッド 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用
MX351881B (es) 2012-03-01 2017-11-01 Firststring Res Inc Geles tópicos que contienen péptidos de alfa-conexina c- terminal (act).
US20140031753A1 (en) * 2012-07-25 2014-01-30 Neil T. Winthrop Thoracostomy devices and methods of use
US9156896B2 (en) * 2013-03-15 2015-10-13 Coda Therapeutics, Inc. Wound healing compositions and treatments
WO2015130840A2 (en) * 2014-02-25 2015-09-03 Coda Therapeutics, Inc. Treatment of resistant lesions
WO2016029191A2 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
HK1249108A1 (zh) * 2015-01-20 2018-10-26 米拉根医疗股份有限公司 Mir-92抑制剂及其用途
CN111201247A (zh) 2017-04-28 2020-05-26 奥克兰联合服务有限公司 治疗方法和新颖构建体
CN109513037B (zh) * 2018-11-14 2021-09-17 华中科技大学同济医学院附属协和医院 一种负载介孔生物玻璃的小肠粘膜下层创面敷料
WO2021119198A1 (en) * 2019-12-09 2021-06-17 Cage Bio, Inc. Topical delivery of rna interference agents using ionic liquid
CN111214694B (zh) * 2020-03-31 2022-04-22 山东大鱼生物技术有限公司 一种具有止血和加速伤口愈合功能的敷料及其制备方法
US12138293B2 (en) 2020-10-22 2024-11-12 Xequel Bio, Inc. Peptide formulations and ophthalmic uses thereof
US12667586B2 (en) 2023-03-07 2026-06-30 Glaukos Corporation Treatments for ocular surface disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0539594Y2 (enExample) * 1988-08-05 1993-10-07
US5166195A (en) * 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
US7098190B1 (en) * 1999-01-27 2006-08-29 Coda Therapeutics Ltd. Formulations comprising antisense nucleotides to connexins
US7250397B2 (en) * 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
US20050119211A1 (en) * 2001-05-18 2005-06-02 Sirna Therapeutics, Inc. RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
CN1939529A (zh) * 2002-01-29 2007-04-04 Wyeth公司 用于调节连接蛋白半通道的组合物和方法
EP1827480B1 (en) * 2004-12-21 2016-11-09 MUSC Foundation For Research Development Compositions and methods for promoting wound healing and tissue regeneration
CN101573131B (zh) * 2005-02-03 2017-12-01 科达治疗有限公司 抗‑连接蛋白化合物及其治疗应用
RU2542471C2 (ru) * 2006-11-15 2015-02-20 Коуда Терапьютикс, Инк. Улучшенные способы и композиции для заживления ран
PL2101791T3 (pl) * 2006-12-11 2015-04-30 Coda Therapeutics Inc Preparaty i metody leczenia ran z nieprawidłowym przebiegiem gojenia
AU2008335717A1 (en) * 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
EP2252690A2 (en) * 2007-12-21 2010-11-24 Coda Therapeutics, Inc. Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
US20110243964A1 (en) * 2007-12-21 2011-10-06 Bradford James Duft Treatment of orthopedic conditions
EP2237795A2 (en) * 2007-12-21 2010-10-13 Coda Therapeutics, Inc. Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions
EP2237796A2 (en) * 2007-12-21 2010-10-13 Coda Therapeutics, Inc. Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions
WO2009097077A2 (en) * 2008-01-07 2009-08-06 Coda Therapeutics, Inc. Wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
JP2011508605A5 (enExample)
RU2009122370A (ru) Улучшенные способы и композиции для заживления ран
JP2011507861A5 (enExample)
JP2011507858A5 (enExample)
JP2025128190A5 (enExample)
JP2022031772A5 (enExample)
JP2011507855A5 (enExample)
CN102718858B (zh) 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用
US8975237B2 (en) Treatment of fibrotic conditions
JP2010512404A5 (enExample)
US20110130710A1 (en) Treatment of abnormal or excessive scars
SA517381997B1 (ar) تركيبة لتضميد الجرح
JP2019214592A (ja) ベンダムスチンの製剤
RU2009126594A (ru) Композиции и способы лечения плохо заживающих ран
CN102920996A (zh) 受损伤口愈合的药物组合物
US20110144182A1 (en) Treatment of surgical adhesions
CN104271149A (zh) 经皮递送装置
JP2015083606A (ja) 線維症性の状態の治療のための抗コネキシンポリヌクレオチド剤と組み合わせた抗コネキシンポリペプチド剤の使用
US20140275209A1 (en) Wound healing compositions and treatments
KR20120014251A (ko) 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법
JP6196704B2 (ja) 神経因性疾病の治療のための医薬
CN101896190A (zh) 用α胸腺肽和抗细胞毒性T淋巴细胞相关抗原4(CTLA4)的抗体的组合治疗黑素瘤
AU2006206393A1 (en) Methods for treating adhesive capsulitis
CN102049061A (zh) 一种壳聚糖胶原海绵烧伤敷料的制备方法
WO1996002270A1 (en) Use of insulin-like growth factor in combination with insulin